Alejandra González-Duarte Selected Research

Amyloid Neuropathies (Amyloid Neuropathy)

5/2024	Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis.
6/2020	Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alejandra González-Duarte Research Topics

Disease

11	Amyloidosis 05/2024 - 01/2019
7	Polyneuropathies (Polyneuropathy) 05/2024 - 12/2013
4	Transthyretin-Related Hereditary Amyloidosis 01/2022 - 01/2019
2	Amyloid Neuropathies (Amyloid Neuropathy) 05/2024 - 06/2020
2	Ataxia (Dyssynergia) 01/2023 - 01/2021
2	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 03/2016 - 01/2016
1	Disease Progression 05/2024
1	Small Fiber Neuropathy 05/2024
1	Body Weight (Weight, Body) 10/2023
1	Spasm (Spasms) 10/2023
1	Arthralgia (Joint Pain) 10/2023
1	Blindness (Hysterical Blindness) 01/2023
1	Albuminuria 12/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2022
1	Inflammation (Inflammations) 11/2022
1	Hypoxia (Hypoxemia) 11/2022
1	Edema (Dropsy) 11/2022
1	Pure Autonomic Failure 10/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021
1	Amyloid Plaque 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Headache (Headaches) 01/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Rhabdomyolysis 01/2021
1	Immunoglobulin G4-Related Disease 01/2021
1	Stroke (Strokes) 01/2021
1	Rare Diseases (Rare Disease) 01/2021
1	COVID-19 10/2020
1	Diabetic Neuropathies (Diabetic Neuropathy) 09/2020
1	Orthostatic Intolerance 03/2020
1	Orthostatic Hypotension (Postural Hypotension) 12/2019
1	Weight Loss (Weight Reduction) 12/2019
1	Diarrhea 12/2019
1	Autonomic Nervous System Diseases (Dysautonomia) 12/2019
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Pain (Aches) 11/2016
1	Neuralgia (Stump Neuralgia) 11/2016
1	Glucose Intolerance 11/2016
1	Syndrome (Syndromes) 03/2016
1	Familial Amyloidosis (Hereditary Amyloidosis) 12/2013
1	Leukoencephalopathies 10/2013
1	Opportunistic Infections (Opportunistic Infection) 10/2011
1	Seizures (Absence Seizure) 01/2008

Drug/Important Bio-Agent (IBA)

14	Prealbumin (Transthyretin)IBA 05/2024 - 12/2013
6	patisiranIBA 10/2023 - 01/2019
5	Amyloid (Amyloid Fibrils)IBA 05/2024 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 11/2016
1	tafamidisIBA 05/2024
1	Biomarkers (Surrogate Marker)IBA 05/2024
1	Retinaldehyde (Retinal)IBA 01/2023
1	Fibric Acids (Fibrates)IBA 12/2022
1	NAD (NADH)IBA 12/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	Congo RedIBA 01/2022
1	alpha-SynucleinIBA 10/2021
1	AA amyloidosisIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	CreatinineIBA 01/2021
1	N-Methylaspartate (NMDA)IBA 01/2021
1	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 10/2020
1	hydroxide ionIBA 12/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019
1	Pregabalin (Lyrica)FDA Link 11/2016
1	Levamisole (Decaris)FDA Link 10/2013
1	Cocaine (Cocaine HCl)IBA 10/2013
1	Myelin Basic ProteinIBA 10/2011
1	PS 5 (PS-5)IBA 01/2008

Therapy/Procedure

3	Artificial Respiration (Mechanical Ventilation) 11/2022 - 10/2020
3	RNAi Therapeutics 09/2020 - 03/2020
1	Denervation 05/2024
1	Therapeutics 01/2021